FLUOROURACIL
ACTINIC KERATOSES AGENTS · SUPERFICIAL BASAL CELL CARCINOMA ·+1
Mylan Pharmaceuticals
Drug class
Topical Antineoplastic Alkylating Agents
Topical antineoplastic alkylating agents are locally administered anticancer medications designed to deliver cytotoxic therapy directly to cutaneous lesions while minimizing systemic absorption. Read more about Topical Antineoplastic Alkylating Agents
34 drugs in this class 27 manufacturers
Drugs in Topical Antineoplastic Alkylating Agents
FLUOROPLEX (fluorouracil)
ACTINIC KERATOSES AGENTS · ACTINIC KERATOSIS
AQUA PHARMACEUT
FLUOROURACIL
ACTINIC KERATOSES AGENTS · SUPERFICIAL BASAL CELL CARCINOMA ·+1
TARO PHARM USA
FLUOROURACIL
ACTINIC KERATOSES AGENTS · ACTINIC KERATOSIS
TARO PHARM USA
DICLOFENAC SODIUM
ACTINIC KERATOSES AGENTS · OSTEOARTHRITIS OF THE KNEE ·+1
TARO PHARM USA
DICLOFENAC SODIUM
ACTINIC KERATOSES AGENTS · OSTEOARTHRITIS OF THE KNEE ·+1
PHARMACEUTICA N
TOLAK (fluorouracil)
ACTINIC KERATOSES AGENTS · ACTINIC KERATOSIS
HILL DERM
EFUDEX (fluorouracil)
ACTINIC KERATOSES AGENTS · SUPERFICIAL BASAL CELL CARCINOMA ·+1
Bausch Health US
BEXAROTENE
SELECTIVE RETINOID X RECEPTOR AGONISTS · CUTANEOUS T-CELL LYMPHOMA
Amneal Pharmaceuticals
Filter & compare in the drug finder →
Opens the drug finder with Topical Antineoplastic Alkylating Agents preselected. Add indication or manufacturer filters there.
Topical antineoplastic alkylating agents are locally administered anticancer medications designed to deliver cytotoxic therapy directly to cutaneous lesions while minimizing systemic absorption.
As bifunctional or polyfunctional alkylating agents—most notably mechlorethamine (nitrogen mustard)—they exert their therapeutic effect by transferring alkyl groups to cellular DNA, causing interstrand cross-linking, inhibition of DNA replication and transcription, and subsequent apoptotic cell death in rapidly proliferating malignant cells.
Therapeutically, this specialized drug class serves as skin-directed chemotherapy primarily indicated for the treatment of early-stage cutaneous T-cell lymphoma, specifically mycosis fungoides.
-
oup.com
Topical antineoplastic alkylating agents are locally administered anticancer medications designed to deliver cytotoxic therapy directly to cutaneous lesions while minimizing systemic absorption Therapeutically, this specialized drug class serves as skin-directed chemotherapy primarily indicated for the treatment of early-stage cutaneous T-cell lymphoma, specifically mycosis fungoides
-
nih.gov
As bifunctional or polyfunctional alkylating agents—most notably mechlorethamine (nitrogen mustard)—they exert their therapeutic effect by transferring alkyl groups to cellular DNA, causing interstrand cross-linking, inhibition of DNA replication and transcription, and subsequent apoptotic cell death in rapidly proliferating malignant cells
-
cancer.gov
As bifunctional or polyfunctional alkylating agents—most notably mechlorethamine (nitrogen mustard)—they exert their therapeutic effect by transferring alkyl groups to cellular DNA, causing interstrand cross-linking, inhibition of DNA replication and transcription, and subsequent apoptotic cell death in rapidly proliferating malignant cells
-
fda.gov
Therapeutically, this specialized drug class serves as skin-directed chemotherapy primarily indicated for the treatment of early-stage cutaneous T-cell lymphoma, specifically mycosis fungoides
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.